BioTools Inc Profile last edited on: 3/27/14
CAGE: 3EX07
UEI:
Business Identifier: biopharmaceuticals and chiral-organic drugs 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Multiple
Congr. District: 18
County: Palm Beach
Congr. District: 18
County: Palm Beach
Public Profile
BioTools provides instrumentation and services to pharmaceutical and biotechnology companies in several niche markets. They concentrate in the areas of biopharmaceuticals and chiral-organic drugs. Their unique products are used for molecular structure characterization from active ingredient to formulated finished products. BioTools was the first company to commercialize two ground-breaking techniques in vibrational spectroscopy - Vibrational Circular Dichroism (VCD) and Raman Optical Activity (ROA). VCD is the most sought after technique for determination of absolute configuration of chiral molecules, including natural products and chiral API's. ROA is mostly used for structure characterization of glyco-proteins, proteins, viruses and nucleic acids.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
1-4Awards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2013 | 2 | NSF | $601,690 | |
| Project Title: Vibrational CD Microscopy for Characterizing Supramolecular Bio-Chirality | ||||
| 2007 | 2 | AF | $850,000 | |
| Project Title: Surface-Enhanced Detection of Molecular and Biomolecular Species | ||||
Key People / Management
Rina Dukor -- President
Laurence A Nafie
Laurence A Nafie
Company News
There are no news available.
